Sickle Cell Disease News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Review Board Finds Global Blood's Sickle Cell Disease Therapy Voxelotor Is Safe - Sickle Cell Anemia News



Review Board Finds Global Blood's Sickle Cell Disease Therapy Voxelotor Is Safe 
Sickle Cell Anemia News
An independent review board has found Global Blood Therapeutics' sickle cell disease treatment voxelotor safe, and recommended that its Phase 3 clinical trial continue. The hallmark of sickle cell disease is damage to a red blood cell protein called ...
Sickle Cell Disease Market Research and Development 2017 to 2025 Research of Market

all 2 news articles » 


An Integrated Research On Global Blood Therapeutics: Is Voxelotor The Answer For Sickle Cell Disease? - Seeking Alpha



Seeking Alpha
 
An Integrated Research On Global Blood Therapeutics: Is Voxelotor The Answer For Sickle Cell Disease? 
Seeking Alpha
The independent data and safety monitoring board completed the safety review of the phase 3 HOPE trial. With safety issue as our main concern out of the way, we're more confident in our bull thesis on the company. Third quarter reported significant ...
Somewhat Favorable Media Coverage Somewhat Unlikely to Affect ... The Ledger Gazette
7 Breakout Stocks for 2018 Zacks.com
SEC FORM 4 - SEC.gov SEC.gov

all 82 news articles » 


Sickle Cell Patients Endure Discrimination, Poor Care And Shortened Lives - NPR



NPR
 
Sickle Cell Patients Endure Discrimination, Poor Care And Shortened Lives 
NPR
Patients and experts alike say it's no surprise then that while life expectancy for almost every major malady is improving, patients with sickle cell disease can expect to die younger than they did more than 20 years ago. In 1994, life expectancy for ...
Sickle Cell Patients Suffer Discrimination, Poor Care ? And Shorter Lives Gilmer Mirror

all 2 news articles » 


Sickle Cell Disease - Epidemiology Forecast to 2025 - PR Newswire (press release)



Sickle Cell Disease - Epidemiology Forecast to 2025 
PR Newswire (press release)
DelveInsight's "Sickle Cell Disease -Epidemiology Forecast, 2025" provides an overview of the epidemiology trends of Sickle Cell Disease in seven major markets (US, France, Germany, Italy, Spain, UK and Japan).

and more » 


New research happening at MCG to fight Sickle Cell Disease - WJBF-TV



WJBF-TV
 
New research happening at MCG to fight Sickle Cell Disease 
WJBF-TV
The Medical College of Georgia and Augusta University Health are part of a national trial studying if bone marrow transplants should be given to all patients suffering from Sickle Cell Disease. MCG is one of about 35 centers across the country ...
Popular Alzheimer's drug shows promise in clinical trials for treating patients with sickle cell disease News-Medical.net
First evaluation of sickle cell screening programme published Medical Xpress
Out of Balance: Gut Bacterial Makeup May Exacerbate Pain in Sickle Cell Disease Newswise (press release)
The Global Health News (press release) (blog)  -Medgadget (blog) 
all 9 news articles » 


Longtime sickle cell disease survivor Earline Washington talks about survival, community outreach efforts - The Tand D.com



The Tand D.com
 
Longtime sickle cell disease survivor Earline Washington talks about survival, community outreach efforts 
The Tand D.com
Vance resident Earline Washington, 69, is a longtime survivor of sickle cell disease and works tirelessly to promote awareness within the community as part of the Orangeburg Area Sickle Cell Foundation and Palmetto Health Richland's Sickle Cell Disease ...

 


Oakland Center Finds Sickle Cell Treatment Success - NPR



Oakland Center Finds Sickle Cell Treatment Success 
NPR
Jenny Gold has a two-part - has Part 2 of our series on sickle cell disease and discrimination. JENNY GOLD, BYLINE: Derek Perkins sits on the end of the exam table at the Adult Sickle Cell Center at Children's Hospital Oakland. He's short but strong ...
Global Sickle Cell Disease Treatment Market is Estimated to Represent US$ 584.0 Mn by 2025 Medgadget (blog)

all 2 news articles » 


Sickle Cell Patient with Severe Anemia Rapidly Improves with Voxelotor, Case Study Shows - Sickle Cell Anemia News



Sickle Cell Patient with Severe Anemia Rapidly Improves with Voxelotor, Case Study Shows 
Sickle Cell Anemia News
Global Blood Therapeutics (GBT) reported a case study in which a sickle cell disease (SCD) patient was granted compassionate access to the company's ongoing Phase 3 HOPE study of voxelotor (NCT03036813). The patient had severe, ...

 


Global Blood Therapeutics Announces Completion of Safety Review by Independent Data and Safety Monitoring Board ... - GlobeNewswire (press release)



Global Blood Therapeutics Announces Completion of Safety Review by Independent Data and Safety Monitoring Board ... 
GlobeNewswire (press release)
... the independent Data and Safety Monitoring Board (DSMB) for the Phase 3 HOPE (Hemoglobin Oxygen Affinity Modulation to Inhibit HbS PolymErization) Study evaluating voxelotor (previously called GBT440) for the treatment of sickle cell disease (SCD), ...
Global Blood's late-stage study of SCD candidate voxelotor to continue as planned, enrollment expanded to ... Seeking Alpha

all 2 news articles » 


Genotype may help identify patients at increased risk for sickle cell disease-related complications - News-Medical.net



Genotype may help identify patients at increased risk for sickle cell disease-related complications 
News-Medical.net
Researchers have found a genotype that could help identify sickle cell disease (SCD) patients at greatest risk of common, yet severe, complications of SCD. The findings will be presented today at the American Physiological Society's Physiological and ...

and more »